China Preclinical Imaging Market Size & Outlook, 2026-2033

Name: China Preclinical Imaging Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The preclinical imaging market in China is expected to reach a projected revenue of US$ 126.0 million by 2033. A compound annual growth rate of 7.2% is expected of China preclinical imaging market from 2026 to 2033.

China preclinical imaging type outlook (Revenue, USD million, 2021-2033)
- Modality
  - Optical Imaging (BLI & F)
  - Magnetic Resonance Imaging (MRI)
  - Positron Emission Tomography (PET)
  - Single Photon Emission Computed Tomography (SPECT)
  - Computed Tomography (CT)
  - Ultrasound Imaging (US)
  - Photoacoustic Imaging (PAI)
  - Hybrid Imaging Systems (Bi-modal, Tri-modal, Multi-modal)
  - Others Modality
- Reagent
- Service
China preclinical imaging application outlook (Revenue, USD million, 2021-2033)
- Drug Discovery & Development
- Toxicology & Pharmacokinetics Studies
- Basic & Translational Research
- Disease Mechanism & Pathophysiology Studies
  - Oncology
  - Cardiology
  - Neurology
  - Infectious Diseases
  - Immunology & Inflammation
  - Others Disease Mechanism & Pathophysiology Studies
- Biomarker & Imaging Agent Validation
- Others Application
China preclinical imaging end use outlook (Revenue, USD million, 2021-2033)
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others End Use

China Preclinical Imaging Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!